Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3D88P | ISIN: US78423T2006 | Ticker-Symbol:
NASDAQ
28.03.24
14:30 Uhr
6,060 US-Dollar
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SHL TELEMEDICINE LTD ADR Chart 1 Jahr
5-Tage-Chart
SHL TELEMEDICINE LTD ADR 5-Tage-Chart

Aktuelle News zur SHL TELEMEDICINE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiSHL TELEMEDICINE LTD - 6-K, Report of foreign issuer1
14.03.SHL Telemedicine erhält eine Kaufempfehlung mit einem Kursziel von $11,00203Ein führendes Aktienforschungsunternehmen gibt ein zweistelliges Kursziel für SHL Telemedicine an und positioniert das Unternehmen als eine unterbewertete Gelegenheit angesichts seiner einzigartigen...
► Artikel lesen
14.03.SHL Telemedicine Receives Buy Rating with $11.00 Price Target641A leading equity research firm provides a double-digit price target for SHL Telemedicine, positioning it as an undervalued opportunity considering its unique technology, expertise and expanding...
► Artikel lesen
14.03.SHL TELEMEDICINE LTD - 6-K, Report of foreign issuer2
14.03.Litchfield Hills sees SHL Telemedicine stock undervalued, sets $11 target4
14.03.SHL-Telemedicine-Chef tritt zurück4
05.02.SHL TELEMEDICINE LTD - 6-K, Report of foreign issuer3
01.02.SHL Telemedicine Ltd.: Imperial College London TELE-ACS Clinical Trial Results, Using SHL Telemedicine's SmartHeart Technology, to Be Presented at ACC 24368The selection of the TELE-ACS trial results for presentation at ACC 24 highlights the pioneering achievements of Imperial College London and SHL in advancing the field of telemedicine SHL Telemedicine...
► Artikel lesen
28.12.23SHL TELEMEDICINE LTD - 6-K, Report of foreign issuer5
19.12.23SHL Telemedicine Ltd.: SHL Telemedicine and BARMER to Highlight Digital Patient Care at BMC Congress 2024432SHL Telemedicine German Operation and BARMER, one of the top health insurance funds in Germany, to present at leading Germany Healthcare Conference SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN...
► Artikel lesen
06.11.23SHL Telemedicine Ltd.: SHL Telemedicine Establishes US Nationwide Cardiology Network for ECG Interpretations and Telehealth Visits396Pioneering a New Era of Cardiac Care, SHL Telemedicine Established a Comprehensive Network to Broaden Access to Expert Cardiology Services for B2B and Direct-to-Consumer Segments through its SmartHeart®...
► Artikel lesen
23.10.23SHL Telemedicine Ltd.: SHL Telemedicine Announces Advancements in its Direct-to-Consumer Strategy in the US370Making Significant Investments in Infrastructure and Technology, SHL Telemedicine Advances its US Direct-to-Consumer Strategy Post Positive Initial Trial Results SHL Telemedicine Ltd. (NASDAQ:...
► Artikel lesen
26.09.23SHL Telemedicine Ltd.: SHL Telemedicine's SmartHeart Technology Shows Remarkable Effects in Mayo Clinic and Imperial College London Trials436Promising outcomes indicate significant reductions in emergency visits and hospital readmissions, alongside reductions in healthcare utilization costs relating to post-MI patient treatment SHL...
► Artikel lesen
21.09.23SHL Telemedicine Ltd.: SHL Announces Half-Year Results 2023 - Strategic Moves to Accelerate Growth965Regulatory News: SHL Telemedicine Ltd. (NASDAQ: SHLT; SIX Swiss Exchange: SHLTN) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, announced...
► Artikel lesen
11.09.23SHL Telemedicine Ltd.: SHL Telemedicine's SmartHeart Technology to Take Center Stage at Upcoming VPM 2023 Conference464Initial results from the Mayo Clinic HELP-MI and the Imperial College London TELE-ACS trials to be presented at the Vulnerable Plaque and Patient Meeting (VPM) 2023. SHL Telemedicine Ltd. (NASDAQ:...
► Artikel lesen
15 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1